Abstract
Background The time course of events after acute coronary syndromes might influence the timing and duration of therapeutic interventions. We investigated the impact of risk status and ST-segment category at presentation.
Methods The timing of death, reinfarction, stroke and major bleeding within 6 months of acute coronary syndromes was determined in 46,829 patients enrolled in the Global Registry of Acute Coronary Events (GRACE). Acute coronary syndromes were classified by elevation (n = 17,668), depression (n = 8,542), or neither (n = 20,619) in the ST segment. GRACE risk scores and hazard ratios (HR) were determined for three time periods: 0–4, 5–15 and 16–180 days.
Results ST-segment elevation was associated with a higher early risk of death than was ST-segment depression (0–4 days, HR 1.89, 95% CI 1.60–2.24 versus 5–15 days, HR 1.26, 95% CI 1.05–1.50), but after 15 days the risk was reversed (16–180 days, HR 0.85, 95% CI 0.75–0.97). Throughout the study, patients with ST-segment deviation had a higher mortality risk than those without. Within each ST category, the highest GRACE risk scores were associated with a 10–40-fold greater risk of death than the lowest scores (all categories P <0.0001). Most deaths occurred after day 4 (57%, 74%, and 78% for ST-segment elevation, depression and neither, respectively).
Conclusion The timing of events after acute coronary syndromes was affected by ST category and influenced by GRACE risk score within each electrocardiographic category of acute coronary syndromes. Risk stratification should, therefore, include multiple risk factors rather than ST shift alone.
Key Points
-
The temporal distribution of postpresentation events (death, infarction, reinfarction, new stroke, and major bleed) in patients hospitalized for an acute coronary syndrome (ACS) varies according to ST category but is powerfully influenced by the GRACE risk score
-
Our data demonstrate a 10–40-fold range of death within each category of ST deviation (ST elevation, ST depression, or no ST deviation); thus, ST segment deviation alone is an inadequate basis for risk prediction
-
Within the first 15 days of presentation with ACS, patients with ST elevation at initial presentation are at greatest risk of death
-
In contrast, in the postdischarge period, there is a higher risk of death in patients with ST depression at initial presentation
-
Almost two-thirds of all events in the first 6 months after hospital presentation occur in the period beyond the first 4 days (66% of deaths, 59% of reinfarctions)
-
For those with ST depression at initial presentation, three-quarters of all the deaths in the first 6 months occur beyond the median period of hospitalization (beyond 4 days)
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hamm C et al. (2006) Acute coronary syndromes: pathophysiology diagnosis and risk stratification. In The ESC Textbook of Cardiovascular Medicine 333–366 (Eds Camm A. et al.) Oxford: Blackwell Publishing
Davies MJ et al. (1993) Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 69: 377–381
Davies MJ (1995) Acute coronary thrombosis—the role of plaque disruption and its initiation and prevention. Eur Heart J 16 (Suppl L): 3–7
Davies MJ (1997) The composition of coronary-artery plaques. N Engl J Med 336: 1312–1314
Terkelsen CJ et al. (2005) Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort. Eur Heart J 26: 18–26
Bassand JP et al. (2007) Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 28: 1598–1660
Bassand JP et al. (2007) Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J 28: 1598–1660
Anderson JL et al. (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 116: 803–877
Granger CB et al. (2003) Predictors of hospital mortality in the Global Registry of Acute Coronary Events. Arch Intern Med 163: 2345–2353
Goldberg RJ et al. (2004) Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol 93: 288–293
Fox KA et al. (2006) Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 333: 1091–1094
Montalescot G et al. (2007) STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry). Eur Heart J 28: 1409–1417
The GRACE Investigators (2001) Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J 141: 190–199
Steg PG et al. (2002) Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol 90: 358–363
Buffon A et al. (2002) Widespread coronary inflammation in unstable angina. N Engl J Med 347: 5–12
Tanaka A et al. (2005) Multiple plaque rupture and C-reactive protein in acute myocardial infarction. J Am Coll Cardiol 45: 1594–1599
Bertrand ME et al. (2002) Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force on the management of acute coronary syndromes of the European Society of Cardiology. Eur Heart J 23: 1809–1840
Braunwald E et al. (2002) ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction—summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 40: 1366–1374
Roe MT et al. (2005) Relationship between risk stratification by cardiac troponin level and adherence to guidelines for non-ST-segment elevation acute coronary syndromes. Arch Intern Med 165: 1870–1876
Haim M et al. (2004) Acute coronary syndromes complicated by symptomatic and asymptomatic heart failure: does current treatment comply with guidelines? Am Heart J 147: 859–864
Fox KA et al. (2003) From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Eur Heart J 24: 1414–1424
Yan AT et al. (2004) One-year outcome of patients after acute coronary syndromes (from the Canadian Acute Coronary Syndromes Registry). Am J Cardiol 94: 25–29
Kulkarni SP et al. (2006) Long-term adherence with cardiovascular drug regimens. Am Heart J 151: 185–191
Eagle KA et al. (2004) Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study. Am J Med 117: 73–81
Wiviott SD et al. (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357: 2001–2015
Fox KA et al. (2007) Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 297: 1892–1900
Acknowledgements
This research was supported by an unrestricted grant from Sanofi-Aventis, Paris, France. We thank the physicians and nurses participating in GRACE. Further information about the project, along with the complete list of participants, can be found at http://www.outcomes.org/grace. The authors are grateful to S Rushton-Smith, who provided editorial support in the preparation of this paper. GRACE is supported by an unrestricted educational grant from Sanofi-Aventis to the Center for Outcomes Research, University of Massachusetts Medical School. Sanofi-Aventis had no involvement in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Competing interests
KAA Fox is a consultant for and is funded by GlaxoSmithKline and Sanofi-Aventis. He is also funded by Merck.
FA Anderson is funded by Sanofi-Aventis, Scios and The Medicines Company. He is a consultant for GlaxoSmithKline.
PG Steg is funded by Sanofi-Aventis. He is a consultant for Astellas, AstraZeneca, Boehringer-Ingelheim, Bristol-Myers Squibb, Endotis Pharma, GlaxoSmithKline, Medtronic, Merck, Nycomed, Sanofi-Aventis, Servier, Takeda and The Medicines Company.
JM Gore is funded by Sanofi-Aventis.
The other authors declared no competing interests.
Rights and permissions
About this article
Cite this article
Fox, K., Anderson Jr, F., Goodman, S. et al. Time course of events in acute coronary syndromes: implications for clinical practice from the GRACE registry. Nat Rev Cardiol 5, 580–589 (2008). https://doi.org/10.1038/ncpcardio1302
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpcardio1302
This article is cited by
-
Effect of PCSK9 inhibitor on lipoprotein particles in patients with acute coronary syndromes
BMC Cardiovascular Disorders (2021)
-
The myth of ‘stable’ coronary artery disease
Nature Reviews Cardiology (2020)
-
Percutaneous coronary intervention in patients hospitalized for non-ST-elevation myocardial infarction and the risk of postdischarge ischemic stroke at 6-month, 1-year, and 3-year follow-ups
Heart and Vessels (2019)
-
Efficacy and Safety of the Use of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Ischemic Heart Disease: A Meta-Analysis of Phase III Randomized Trials
American Journal of Cardiovascular Drugs (2019)
-
Kraftfahreignung bei Herzerkrankungen
Herz (2018)